Form D · Biotechnology

Vivorte Inc.

Louisville, KY · CIK 0001509210

Offering snapshot reported Jul 21, 2022 · SEC filing

Reported sold
$601K
Offering amount: $2.5M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 7, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 21, 2022Initial$600,858No comparison18SEC filing
Mar 31, 2021Initial$321,080No comparison15SEC filing
Sep 14, 2020Initial$894,998No comparison14SEC filing
Sep 14, 2020Amendment$835,001-$156,744vs Apr 28, 202022SEC filing
Apr 28, 2020Initial$991,745No comparison20SEC filing
Oct 3, 2019Initial$350,000No comparison5SEC filing
Nov 29, 2018Initial$902,224No comparison30SEC filing
Nov 29, 2018Initial$410,000No comparison8SEC filing
Jul 25, 2013Amendment$4,430,000$3,250,400vs Jan 19, 201174SEC filing
Jan 19, 2011Initial$1,179,600No comparison35SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-453222

Source: Form D, filed Jul 21, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Saunders Director
William Scheessele Director
Michael Voor Director
Ruth Voor Director
Mark Wagner Executive
Peter Weiss Director
Tyree Wilburn Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1044 East Chestnut Street
Louisville, KY, 40204